Allakos Inc. (ALLK) Financials
ALLK Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 283.5 million | 62.5 million |
2023-06-30 | 319.2 million | 64.2 million |
2023-03-31 | 350.4 million | 70.0 million |
2022-12-31 | 386.4 million | 76.0 million |
ALLK Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -29.6 million | 10.5 million |
2023-06-30 | -32.8 million | 9.8 million |
2023-03-31 | -30.4 million | 10.7 million |
2022-12-31 | -47.1 million | 9.3 million |
ALLK Net Income
No data available :(
ALLK Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 193.9 million | - | 41.8 million |
2023-06-30 | 221.1 million | - | 39.7 million |
2023-03-31 | 252.6 million | - | 43.4 million |
2022-12-31 | 279.8 million | - | 49.1 million |
ALLK Shares Outstanding
ALLK Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 107000 | 36.7 million | 11.5 million | - |
2023-06-30 | 252000 | 27.3 million | 10.5 million | - |
2023-03-31 | 267000 | 33.1 million | 12.0 million | - |
2022-12-31 | 291000 | 35.4 million | 10.8 million | - |
ALLK Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 1.5 million |
2023-06-30 | - | 1.8 million |
2023-03-31 | - | 2.0 million |
2022-12-31 | - | 2.0 million |
ALLK
Price: $1.10
52 week price:
Earnings Per Share: -2.14 USD
P/E Ratio: -0.80
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 140771
Market Capitalization: 105.4 million